SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-020864
Filing Date
2022-11-01
Accepted
2022-11-01 16:31:46
Documents
85
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rgen-20220930.htm   iXBRL 10-Q 4118980
2 EX-31.1 rgen-ex31_1.htm EX-31.1 18517
3 EX-31.2 rgen-ex31_2.htm EX-31.2 18482
4 EX-32.1 rgen-ex32_1.htm EX-32.1 26969
  Complete submission text file 0000950170-22-020864.txt   15054657

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rgen-20220930.xsd EX-101.SCH 69501
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rgen-20220930_def.xml EX-101.DEF 476507
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rgen-20220930_pre.xml EX-101.PRE 555688
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rgen-20220930_cal.xml EX-101.CAL 68304
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rgen-20220930_lab.xml EX-101.LAB 620773
79 EXTRACTED XBRL INSTANCE DOCUMENT rgen-20220930_htm.xml XML 3367416
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-14656 | Film No.: 221350889
SIC: 2836 Biological Products, (No Diagnostic Substances)